Led by drugs, pharma sector, India's exports from SEZs rise 41.5 percent in Q1FY22

Published On 2021-09-01 03:30 GMT   |   Update On 2021-09-01 10:43 GMT

New Delhi: Led by drugs and pharmaceuticals, India's exports from special economic Zones (SEZs) rose by 41.5 per cent on a year-on-year (YoY) basis to Rs 2.15 lakh crore in Q1FY22. Exports from these zones had taken a hit during the fiscal year 2020-21 due to Covid disruptions and lockdown. The main reasons for the growth in exports from SEZs in April-June quarter has been good performer...

Login or Register to read the full article

New Delhi: Led by drugs and pharmaceuticals, India's exports from special economic Zones (SEZs) rose by 41.5 per cent on a year-on-year (YoY) basis to Rs 2.15 lakh crore in Q1FY22.

Exports from these zones had taken a hit during the fiscal year 2020-21 due to Covid disruptions and lockdown.

The main reasons for the growth in exports from SEZs in April-June quarter has been good performer shown by drugs and pharmaceuticals sectors that are meeting the global needs of medicines amidst the pandemic. But the performance of engineering goods and gems and jewellery sectors has also been good.

In FY21, exports from SEZs fell to Rs 7.6 lakh crore from Rs 7.97 lakh crore in FY20 due to Covid-19.

Read also: NPPA panel fixes retail price of Vildagliptin, Metformin FDCs marketed by Aristo Pharma

As on 30 June 2021, 267 out of a total of 427 SEZs approved by the government are operational.

Further, about Rs 6.25 lakh crore has been invested in these SEZs which employ about 2.5 million people.

Read also: Everstone Capital buys controlling stake in Calibre Chemicals for Rs 730 crore



Tags:    
Article Source : IANS

Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement/treatment or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2024 Minerva Medical Treatment Pvt Ltd

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News